Evidence map›Paper›PMID 33311759›Full record

ArticleMissouri medicine

Current Endovascular Treatment of Acute Ischemic Stroke.

Kunal Bhatia, Sachin Bhagavan, Navpreet Bains, Brandi French, Farhan Siddiq, Camilo R Gomez, Adnan I Qureshi

Open access · greenAbstract read
In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Detrimental influence of Arginase-1 in infiltrating macrophages on poststroke functional recovery and inflammatory milieu.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2021
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kunal BhatiaMSMA member since 2020, University of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Sachin BhagavanUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Navpreet BainsUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Brandi FrenchUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Farhan SiddiqUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Camilo R GomezUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
Adnan I QureshiUniversity of Missouri - Columbia School of Medicine/MU Health Care in Columbia, Missouri.
University of Missouri Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute ischemic stroke is one of the leading causes of death and long-term disability in the United States. Intravenous thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) has been the mainstay of acute therapy. However, multiple randomized clinical trials have been published that have shown higher rates of recanalization and improved functional outcomes with endovascular therapy compared with intravenous rt-PA in patients with ischemic stroke from large vessel occlusion. This article provides an update and discusses the role of endovascular therapy in management of acute ischemic stroke.

Indexed as

Brain IschemiaIschemic StrokeStrokeFibrinolytic AgentsHumansThrombolytic TherapyTreatment OutcomeFibrinolytic Agents

Identifiers

PMID33311759
PMCPMC7723144
OpenAlexW3117342819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.